Log in to search using one of your social media accounts:

 

Cura Cannabis Is Now Producing Montel Williams' CBD Line For Nationwide Sale
The fast-growing cannabis oil company will distribute Williams'personal line of hemp-derived products in all 50 states. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 17, 2018 Category: Pharmaceuticals Authors: Janet Burns, Women at Forbes Source Type: news

Here are the pharma companies accused of blocking generic competition
To prove a generic drug is as safe and effective as the branded version, pharmaceutical companies have to hand over upwards of 1,000 doses of the product to a generic developer. But if the manufacturer creating the generic drug cannot get its hands on enough sample, the development and testing process slows down. It could potentially even keep a generic version of the drug from ever reaching the market. If companies developing generics have trouble accessing the samples they need, they can file a complaint with the FDA. Today, the FDA published a list of 39 pharmaceutical companies that have been the subjects of such compl...
Source: Mass Device - May 17, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Pharmaceuticals Regulatory/Compliance Wall Street Beat Actelion Celgene FDA Gilead Sciences GlaxoSmithKline plc johnsonandjohnson Novartis Valeant Pharmaceuticals Source Type: news

Correvio Announces Enrollment of First Patient in Phase 3 Study Evaluating Brinavess(R) in China
VANCOUVER, May 17, 2018 -- (Healthcare Sales & Marketing Network) - Correvio Pharma Corp. (NASDAQ: CRME / TSX: COM), formerly Cardiome Pharma Corp., today announced that its partner Eddingpharm has enrolled the first patient in a randomized, double-blind,... Biopharmaceuticals, Cardiology Correvio Pharma, Cardiome Pharma, Brinavess, atrial fibrillation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2018 Category: Pharmaceuticals Source Type: news

Ebola outbreak spreads to first city in DR Congo
WHO officials warn of ‘new phase’ in latest crisis as number of reported cases rises to 45 (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 17, 2018 Category: Pharmaceuticals Source Type: news

Congressional Bill Would Add 1,000 Doctors To Fight Opioid Addiction
The Opioid Workforce Act would create 1,000 new " Medicare-supported " medical residency positions, training “new doctors in addiction medicine, addiction psychiatry or pain management, " Florida U.S. Sen. Bill Nelson said. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 17, 2018 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

CMS Publicizes Costliest Increases for Medicare, Medicaid Drugs CMS Publicizes Costliest Increases for Medicare, Medicaid Drugs
Medicare and Medicaid have faced persistent double-digit increases in the prices of insulin products, as well as notable jumps in the cost of other well-established medicines dating to the 1990s.Medscape Medical News (Source: Medscape Business of Medicine Headlines)
Source: Medscape Business of Medicine Headlines - May 17, 2018 Category: Pharmaceuticals Tags: Family Medicine/Primary Care News Source Type: news

North Carolina joins 5 other states in suing the maker of OxyContin
North Carolina has joined five other states in filing lawsuits against Purdue Pharma, accusing the drug company of igniting the nation ’s opioid crisis by using deceptive marketing practices to sell its painkillers. In marketing its drugs, Purdue Pharma used messages to downplay concerns about addiction and to discredit non-opioid pain relievers, while also pushing for higher doses for its opioid medication and targeting vulner able populations, such as veterans and seniors, N.C. Attorney General… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 17, 2018 Category: Pharmaceuticals Authors: Jessica Seaman Source Type: news

Doctors in US and Canada launch sweeping pharmaceutical reform proposal
The skyrocketing cost of prescription drugs is one of the biggest concerns for American voters. However, in his proposal last Friday, President Donald Trump failed to offer any new policies that would expand access, reduce costs, or increase the safety and efficacy of prescriptions. Today, a group of 21 prominent physicians published a comprehensive proposal to ensure universal access to safe, innovative, and affordable medications. (Source: World Pharma News)
Source: World Pharma News - May 17, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Sharing negotiated discounts at the pharmacy counter could save seniors with diabetes more than $350 annually
Sharing a portion of negotiated rebates at the pharmacy counter could save seniors in Medicare with diabetes more than $350 annually, according to anew analysis from IHS Markit. The data also show sharing negotiated rebates could save Medicare nearly $1000 annually for every senior taking diabetes medication and reduce total health care spending by approximately $20 billion over the next ten years.“Robust competition and choice in Medicare Part D has led to expanded coverage and stable premiums, but more needs to be done to improve affordability and predictability for seniors,” said Stephen J. Ubl, president an...
Source: The Catalyst - May 17, 2018 Category: Pharmaceuticals Tags: drug cost Medicare out of pocket costs Source Type: news

SMi presents the launch of Cell & Gene Therapy 2018
10 - 11 October, London, UK. SMi introduces their inaugural event on Cell & Gene Therapy which takes place between the 10th and 11th October 2018, with an interactive pre-conference workshop on the 9th October. Cell and gene therapeutics have revolutionised modern medicine and mark a new generation in biomedical and agricultural sciences. The latest developments in cell and gene therapies and specifically in gene editing, technologies present unlimited research opportunities ranging from novel therapeutic tools to a potential revolution in the field of drug discovery. (Source: World Pharma News)
Source: World Pharma News - May 17, 2018 Category: Pharmaceuticals Tags: Featured Events Source Type: news

Follow-up phase III data showed Roche ’s Alecensa helped people with ALK-positive metastatic non-small cell lung cancer live a median of almost three years without their disease worsening or death
Roche today announced follow-up data from the phase III ALEX study, showing that, as an initial treatment, Alecensa ® (alectinib) significantly reduced the risk of disease progression or death (progression-free survival; PFS) by 57% (hazard ratio [HR]= 0.43, 95% CI: 0.32-0.58) compared to crizotinib after two years of follow-up in people with anaplastic lymphoma kinase (ALK)-positive metastatic (advanced) non-sm all cell lung cancer (NSCLC), as assessed by the investigator. (Source: Roche Investor Update)
Source: Roche Investor Update - May 17, 2018 Category: Pharmaceuticals Source Type: news

Follow-up phase III data showed Roche ’s Alecensa helped people with ALK-positive metastatic non-small cell lung cancer live a median of almost three years without their disease worsening or death
Roche today announced follow-up data from the phase III ALEX study, showing that, as an initial treatment, Alecensa ® (alectinib) significantly reduced the risk of disease progression or death (progression-free survival; PFS) by 57% (hazard ratio [HR]= 0.43, 95% CI: 0.32-0.58) compared to crizotinib after two years of follow-up in people with anaplastic lymphoma kinase (ALK)-positive metastatic (advanced) non-sm all cell lung cancer (NSCLC), as assessed by the investigator. (Source: Roche Media News)
Source: Roche Media News - May 17, 2018 Category: Pharmaceuticals Source Type: news

Phase III IMpower150 study showed Roche ’s Tecentriq and Avastin plus carboplatin and paclitaxel helped people with a specific type of metastatic lung cancer live significantly longer compared to Avastin plus carboplatin and paclitaxel
Roche today announced positive results from the Phase III IMpower150 study of Tecentriq ® (atezolizumab) and Avastin® (bevacizumab) plus carboplatin and paclitaxel (chemotherapy) for the initial (first-line) treatment of chemotherapy-naïve people with metastatic non-squamous non-small cell lung cancer (NSCLC). (Source: Roche Investor Update)
Source: Roche Investor Update - May 17, 2018 Category: Pharmaceuticals Source Type: news

Phase III IMpower150 study showed Roche ’s Tecentriq and Avastin plus carboplatin and paclitaxel helped people with a specific type of metastatic lung cancer live significantly longer compared to Avastin plus carboplatin and paclitaxel
Roche today announced positive results from the Phase III IMpower150 study of Tecentriq ® (atezolizumab) and Avastin® (bevacizumab) plus carboplatin and paclitaxel (chemotherapy) for the initial (first-line) treatment of chemotherapy-naïve people with metastatic non-squamous non-small cell lung cancer (NSCLC). (Source: Roche Media News)
Source: Roche Media News - May 17, 2018 Category: Pharmaceuticals Source Type: news

AARP Applauds Trump For Taking First Step In Cutting Prescription Drug Costs
“There is no justifiable reason for Americans to pay the highest prescription drug prices in the world. High-priced drugs hurt everyone...,” said AARP's Nancy LeaMond on Trump's blueprint for bringing down drug costs. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 17, 2018 Category: Pharmaceuticals Authors: Robin Seaton Jefferson, Contributor Source Type: news

Catalent Completes $5.5 Million Phased Clinical Storage Expansion at...
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced it has completed...(PRWeb May 17, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15496534.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 17, 2018 Category: Pharmaceuticals Source Type: news

After Manipal-TPG, IHH extends validity of offer for Fortis
IHH's offer to infuse up to Rs7,400 crore into Fortis and acquire over 50% stake in the company is now valid until May 29, the company told the Malaysian stock exchange on Thursday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 17, 2018 Category: Pharmaceuticals Source Type: news

Retail Audits: The Definitive Guide
Compliantia publishes the BIG one. The most complete, most definitive guide to retail audits.(PRWeb May 17, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15494655.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 17, 2018 Category: Pharmaceuticals Source Type: news

NHS doctors bemoan pain of working with outsourcer Capita
Watchdog says patients put ‘at risk of serious harm’ by contractor’s failures (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 16, 2018 Category: Pharmaceuticals Source Type: news

Express Scripts to remain in St. Louis County, filing says
Express Scripts will remain in St. Louis County following the company's sale to Connecticut-based Cigna, according to a securities filing Wednesday. The $67 billion deal was announced in March, and is expected to close before the end of the year. The Express Scripts unit, to be led by current CEO Tim Wentworth, will continue to operate independently, the filing said. Wentworth will be the president of the Express Scripts division, reporting into the combined company’s CEO. Four of Express Scripts'… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 16, 2018 Category: Pharmaceuticals Authors: Jacob Kirn Source Type: news

NASCAR driver ’s $1.2M gift supports new pediatric ED, oncology clinic
A $1.2 million donation from NASCAR driver Martin Truex Jr. ’s foundation will help Novant Health expand services in the Charlotte market. Truex, along with partner Sherry Pollex, announced that donation on Wednesday. Those funds will be split to establish two separate ventures — the Novant Health Martin Truex Jr. Foundation Children’s Emergency Dep artment in Huntersville and the SherryStrong Integrative Medicine Oncology Clinic in Charlotte. “They really want to give back and they want… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 16, 2018 Category: Pharmaceuticals Authors: Jennifer Thomas Source Type: news

Local app: Medical Memory helps patients remember what happens in the doctor's office
When patients leave an exam room, 80 percent of what their doctors told them is forgotten. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 16, 2018 Category: Pharmaceuticals Authors: Hayley Ringle Source Type: news

Jobs alert: Johnson & Johnson Institute in Lake Nona ready to hire managers
The New Brunswick, N.J.-based Johnson& Johnson ’s (NYSE: JNJ) Human Performance Institute that's expanding in Lake Nona is looking for more people to join its team. The company is constructing its new $18 million, 34,480-square-foot office building about five miles southwest of its existing 17,000-square-foot location at 9757 Lake Nona Clu b Drive. Once completed by year’s end, the new headquarters of the Johnson& Johnson Human Performance Institute — a division of Johnson& Johnson Health … (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 16, 2018 Category: Pharmaceuticals Authors: Veronica Brezina Source Type: news

The $50 Billion'Pre-IPO' Market's Next Step Could Be Turning To Blockchain
Could the multi-billion dollar ‘pre’ Initial Public Offering (IPO) market be poised to turn to the Blockchain and associated distributed ledger technology (DLT) as an effective and efficient model to raise capital for ventures? Some pundits in the DLT and cryptocurrency space think so. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 16, 2018 Category: Pharmaceuticals Authors: Roger Aitken, Contributor Source Type: news

U.S. State Attorneys General Sue Purdue Pharma Over Opioid Epidemic U.S. State Attorneys General Sue Purdue Pharma Over Opioid Epidemic
Six more U.S. states on Tuesday announced lawsuits against OxyContin maker Purdue Pharma LP, accusing the company of fueling a national opioid epidemic by deceptively marketing its prescription painkillers to generate billions of dollars in sales.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 16, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Why one Oregon health insurer is bucking the trend and wants to cut premiums
PacificSource's strategy to manage expenses seems to be bearing fruit. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 16, 2018 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news

Downtown counseling firm capitalizes on location, moves into larger space
McKenzie& Associates officially moved its new downtown location on May 1. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 16, 2018 Category: Pharmaceuticals Authors: Bryan Horwath Source Type: news

Get to know the NBJ's 2018 Health Care Awards winners
On May 9, the Nashville Business Journal celebrated the 2018 Health Care Awards winners at an awards dinner. Our May 18 weekly edition will feature Q&As with the winners, asking everything from what Nashville needs to do to keep its crown as America's health care capital to which area of health care is most ripe for innovation. We decided to give you a sneak peek. Get to know a little about this year's class of winners in the slideshow with this story, and be sure to pick up a print copy Friday… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 16, 2018 Category: Pharmaceuticals Authors: Alison Nash Source Type: news

Iqvia stock drops after FDA questions sales data
Iqvia's stock dropped nearly 8 percent Wednesday after the U.S. Food and Drug Administration issued a statement questioning sales data from the company. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 16, 2018 Category: Pharmaceuticals Authors: Jennifer Henderson Source Type: news

Addition of Cannabidiol May Cut Drop Seizures in Lennox-Gastaut
WEDNESDAY, May 16, 2018 -- The addition of cannabidiol to conventional antiepileptic medication is associated with a reduction in the frequency of drop seizures among patients with Lennox-Gastaut syndrome, according to a study published in the May... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 16, 2018 Category: Pharmaceuticals Source Type: news

Better Diet Quality Associated With Larger Brain Volume
WEDNESDAY, May 16, 2018 -- Better diet quality, including high intake of vegetables, fruit, whole grains, dairy, nuts, and fish, is associated with larger brain volume, according to a study published online May 16 in Neurology. Pauline H. Croll,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 16, 2018 Category: Pharmaceuticals Source Type: news

New Rabies Test Could Radically Change Testing, Treatment
WEDNESDAY, May 16, 2018 -- A new rapid rabies test for animals could revolutionize screening and spare humans unnecessary painful treatment, according to a U.S. Centers for Disease Control and Prevention study published online May 16 in PLOS... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 16, 2018 Category: Pharmaceuticals Source Type: news

Nonprofit Manufacturer Could Keep Generic Drug Costs Down
WEDNESDAY, May 16, 2018 -- A nonprofit manufacturer could help keep generic drug prices down and maintain their supply, according to a perspective piece published in the May 17 issue of the New England Journal of Medicine. Dan Liljenquist, J.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 16, 2018 Category: Pharmaceuticals Source Type: news

Ellis wants to open urgent care center at Mohawk Harbor in Schenectady
Ellis Medicine wants to open an urgent care center and doctor's offices at the newly-built Mohawk Harbor, about a mile away from the Schenectady hospital. The 10,300-square-foot medical office would be on the first floor of a four-story building, according to a certificate of need filed at the state Health Department. The Galesi Group of Rotterdam built the $330 million Mohawk Harbor next to the new Rivers Casino and Resort. The upscale development has apartments, offices, retail space, townhouses… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 16, 2018 Category: Pharmaceuticals Authors: Michael DeMasi Source Type: news

Former Steward Health Care exec alleges sexual harassment, racial discrimination in lawsuit
Steward HealthCare and two of its top executives are facing a lawsuit from the organization ’s former senior director for human resources, who alleged that she was the victim of sexual and racial harassment and ultimately discrimination and retaliation. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 16, 2018 Category: Pharmaceuticals Authors: Jessica Bartlett Source Type: news

Researchers Uncover Gut Bacteria's Potential Role In Multiple Sclerosis
Molecules produced from the breakdown of food by gut bacteria have been shown for the first time to directly affect cells in the central nervous system. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 16, 2018 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news

HHS secretary calls on drug companies to ‘ stop the price hikes ’
After President Donald Trump’s drug pricing speech last week was deemed a “non-event” by analysts, all eyes turned to the secretary of the U.S. Dept. of Health & Human Services, Alex Azar, to see what the former pharma executive viewed as the administration’s top concerns. Azar called on the industry to “stop the price hikes” and cautioned that Trump would not hold back from calling out drug manufacturers by name – an effort echoed by FDA chief Dr. Scott Gottlieb who told STAT that the agency would publish the names of companies that are hindering generic drugs from r...
Source: Mass Device - May 16, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Healthcare Reform Pharmaceuticals Wall Street Beat Dept. of Health & Human Services (HHS) Eli Lilly & Co. Source Type: news

Former Novartis CEO Explains Why His Company Paid Trump Lawyer Michael Cohen $1.2 Million
Joseph Jimenez says that he hired Cohen because he was the only person around who seemed to know how the Trump administration thought. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 16, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NYSE:NVS Source Type: news

Are we prepared for the next pandemic?
‘The Gates Foundation estimates that if a global flu pandemic hit now, 33 million people would die’ (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 16, 2018 Category: Pharmaceuticals Source Type: news

Texas sues OxyContin maker for role in nation's opioid crisis
Texas has joined five other states in filing lawsuits against Purdue Pharma LP, accusing the drug company of igniting the nation ’s opioid crisis by using deceptive marketing practices to sell its painkillers. In marketing its drugs, Purdue Pharma downplayed concerns about addiction while also pushing for higher doses for its opioid medication and targeting vulnerable populations, various attorneys general from the six st ates said May 15. “My office is holding Purdue Pharma accountable for… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 16, 2018 Category: Biotechnology Authors: Jessica Seaman Source Type: news

Amgen Receives European Commission Approval For Repatha ® (Evolocumab) To Prevent Heart Attack And Stroke In Adults With Established Cardiovascular Disease
New Indication Supports Amgen's Commitment to Reduce the Risk of Recurrent Cardiovascular Events Faced by Heart Attack and Stroke Survivors Amgen Announces Efforts to Improve Repatha's Affordability Across Europe for Payers who Significantly Expand Patient Access THOUSAND OAKS, Calif., May 16, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the European Commission (EC) has approved a new indication in the Repatha® (evolocumab) label for adults with established atherosclerotic cardiovascular disease (myocardial infarction, stroke or peripheral arterial disease) to reduce cardiovascular risk by ...
Source: Amgen News Release - May 16, 2018 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

EIP Pharma Secures $20.5 Million in Series B Financing
Proceeds to Support Continued Development of Neflamapimod for Alzheimer's Disease CAMBRIDGE, Mass., May 16, 2018 -- (Healthcare Sales & Marketing Network) -- EIP Pharma, a therapeutics company focused on CNS diseases, today announced the successful com... Biopharmaceuticals, Neurology, Venture Capital EIP Pharma, neflamapimod, p38 alpha, Alzheimer's disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2018 Category: Pharmaceuticals Source Type: news

Texas sues OxyContin maker for alleged role in nation's opioid crisis
Texas has joined five other states in filing lawsuits against Purdue Pharma LP, accusing the drug company of igniting the nation ’s opioid crisis by using deceptive marketing practices to sell its painkillers. In marketing its drugs, Purdue Pharma downplayed concerns about addiction while also pushing for higher doses for its opioid medication and targeting vulnerable populations, various attorneys general from the six st ates said Tuesday. “My office is holding Purdue Pharma accountable for… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 16, 2018 Category: Biotechnology Authors: Jessica Seaman Source Type: news

Hepatitis C-Exposed Infants Not Adequately Screened
WEDNESDAY, May 16, 2018 -- Many infants who are exposed to hepatitis C virus (HCV) during pregnancy are not screened for HCV infection, according to a study published online May 2 in Pediatrics. Catherine A. Chappell, M.D., from the University of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 16, 2018 Category: Pharmaceuticals Source Type: news

PPD Skin Test Enhances Bacillus Calmette-Gu & eacute;rin Tx in Bladder CA
WEDNESDAY, May 16, 2018 -- For patients with non-muscle invasive bladder cancer, undergoing the purified protein derivative skin test prior to bacillus Calmette-Gu érin therapy may have therapeutic impact, according to a study published in the June... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 16, 2018 Category: Pharmaceuticals Source Type: news

Suicide Ideation, Attempts Increasing Among U.S. Children
WEDNESDAY, May 16, 2018 -- From 2008 to 2015 there was an increase in encounters for suicide ideation (SI) and suicide attempts (SAs) among U.S. children, according to a study published online May 16 in Pediatrics. Gregory Plemmons, M.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 16, 2018 Category: Pharmaceuticals Source Type: news

Doctors May Avoid Performing PCI Due to Public Reporting
WEDNESDAY, May 16, 2018 -- Current percutaneous coronary intervention (PCI) public reporting programs could have negative effects, with physicians avoiding PCI in high-risk patients, according to a study published online May 9 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 16, 2018 Category: Pharmaceuticals Source Type: news

Higher CRC Risk With Advanced Adenoma Found on Colonoscopy
WEDNESDAY, May 16, 2018 -- Participants with an advanced adenoma at diagnostic colonoscopy have increased risk of developing colorectal cancer (CRC) relative to those with no adenoma, according to a study published in the May 15 issue of the Journal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 16, 2018 Category: Pharmaceuticals Source Type: news

Disruption of Circadian Rhythm Negatively Impacts Mental Health
WEDNESDAY, May 16, 2018 -- Circadian disruption and lower relative amplitude are both associated with higher risk of susceptibility to mental health issues, according to a study published online May 15 in The Lancet Psychiatry. Laura M. Lyall,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 16, 2018 Category: Pharmaceuticals Source Type: news

Sleep Apnea Rarely Investigated in Older Adults
WEDNESDAY, May 16, 2018 -- A high risk of obstructive sleep apnea (OSA) is common among older adults but is seldom investigated, though when it is investigated, it is almost always confirmed, according to a study published online May 9 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 16, 2018 Category: Pharmaceuticals Source Type: news